PENTAERITHRITYL TETRANITRATE (PETN) FOR SECONDARY PREVENTION OF INTRAUTERINE GROWTH RESTRICTION (PETN-TRIAL)

被引：2
|
作者：
Groten, Tanja [1 ]
Schleussner, Ekkehard [1 ]
机构：
[1] Univ Hosp Jena, Dept Obstet, Placentalab, Jena, Germany
来源：
PLACENTA | 2019年 / 83卷
关键词：
D O I：
10.1016/j.placenta.2019.06.254
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
P2.42
引用
收藏
页码：E80 / E80
页数：1
相关论文
共 50 条
  • [1] Pentaerithrityl tetranitrate (PETN) for prevention of fetal growth restriction in pregnancy: A systematic review and meta-analysis
    Heda, Ayush
    Deshwali, Akanksha
    Heda, Sakshi
    Priyadarshi, Mayank
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2024, 24
  • [2] On the efficacy of pentaerithrityl-tetranitrate (PETN) on several parameters of the microcirculation
    Haustein, KO
    Bohm, C
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 424 - 424
  • [3] ABSORPTION AND BIOAVAILABILITY OF PENTAERITHRITYL-TETRANITRATE (PETN, DILCORAN-80)
    HAUSTEIN, KO
    WINKLER, U
    LOFFLER, A
    HULLER, G
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1995, 33 (02) : 95 - 102
  • [4] Pentaeritrithyl Tetranitrate (PETN) for Secondary Prophylaxis of intrauterine Growth Retardation - Presentation of the double-blind randomized PETN Study (AGG-2)
    Groten, T.
    Schleussner, E.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E82 - E83
  • [5] Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial
    Groten, Tanja
    Lehmann, Thomas
    Staedtler, Mariann
    Komar, Matej
    Winkler, Jennifer Lucia
    Condic, Mateja
    Strizek, Brigitte
    Seeger, Sven
    Jaeger, Yvonne
    Pecks, Ulrich
    Eckmann-Scholz, Christel
    Kagan, Karl Oliver
    Hoopmann, Markus
    von Kaisenberg, Constantin S.
    Brodowski, Lars
    Tauscher, Anne
    Schrey-Petersen, Susanne
    Friebe-Hoffmann, Ulrike
    Lato, Krisztian
    Huebener, Christoph
    Delius, Maria
    Verlohren, Stefan
    Sroka, Dorota
    Schlembach, Dietmar
    de Vries, Laura
    Kraft, Katrina
    Seliger, Gregor
    Schleussner, Ekkehard
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : 84.e1 - 84.e12
  • [6] Chronic pentaerithrityl tetranitrate (PETN) treatment does not induce nitrate tolerance and cross-tolerance in Wistar rats
    Coldewey, M
    Dalber, A
    Seeling, A
    Stalleicken, D
    Lehmann, J
    Mülsch, A
    Münzel, T
    CIRCULATION, 2004, 110 (17) : 307 - 307
  • [7] SINGLE-DOSE ORAL BIOAVAILABILITY OF 2 PENTAERITHRITYL-TETRANITRATE (PETN) TABLET FORMULATIONS IN HEALTHY-VOLUNTEERS MEASURED BY RHEOGRAPHY
    HAUSTEIN, KO
    WINKLER, U
    LOFFLER, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 217 - 217
  • [8] First results on the effects of a treatment with nitroglycerin (NTG) and pentaerithrityl tetranitrate (PETN) on the whole genome expression profile in cardiomyocytes - Is there evidence of "cardiotoxic" and "cardioprotective" mechanisms?
    Kleinert, Hartmut
    Daiber, Andreas
    Pautz, Andrea
    Schmidt, Nadine
    Art, Julia
    Wenzel, Philip
    Oelze, Matthias
    Foerstermann, Ulrich
    HERZ, 2009, 34 : 19 - 26
  • [9] DISLOCATIONS IN ENERGETIC MATERIALS .1. THE CRYSTAL-GROWTH AND PERFECTION OF PENTAERYTHRITOL TETRANITRATE (PETN)
    HALFPENNY, PJ
    ROBERTS, KJ
    SHERWOOD, JN
    JOURNAL OF CRYSTAL GROWTH, 1984, 67 (02) : 202 - 212
  • [10] EX-VIVO HUMAN PLACENTAL PERFUSION AS A MODEL FOR EVALUATING PLACENTAL TRANSFER OF PETN TO PREVENT INTRAUTERINE GROWTH RESTRICTION
    Zacarias, Paulina Fuentes
    Retzlik, Franziska
    Pastuschek, Jana
    Yamashita, Michiko
    Groesse, Silke
    Wissenbach, Daniela
    Prieto, Diana Maria Morales
    Markert, Udo
    Groten, Tanja
    PLACENTA, 2023, 140 : E23 - E23
12345